Navigation Links
CEM President and CEO Delivers Commencement Address at the University of Texas at Austin Chemistry and Biochemistry Department Graduation
Date:7/19/2011

MATTHEWS, N.C., July 19, 2011 /PRNewswire/ -- CEM Corporation president and CEO Michael J. Collins delivered the Commencement address for the University of Texas at Austin Chemistry and Biochemistry Department, which was held on May 20, 2011. Collins received his PhD in Physical Chemistry from the University and has been a member of the Advisory Board for the Chemistry Department at the school for a number of years.

(Logo:  http://photos.prnewswire.com/prnh/20090622/CL35336LOGO-b)

"I am honored to have been asked to deliver the Commencement address this year," said Michael J. Collins. "UT has one of the strongest chemistry and biochemistry programs in the country with very talented and promising students. It was wonderful to have the opportunity to share my experiences with them and I appreciate them sharing their special day with me."

Collins told the audience about his time at the University of Texas at Austin and how it helped shape his life. He drew comparisons between the economic outlook when he graduated and the world that today's graduates will be facing, predicting that the same economic trends that brought the prosperity of the past twenty-five years will again bring rapid economic growth in the next five years.

"Technology will continue to transform the world we live in and most of the transformational innovations will be chemistry and biochemistry based," said Collins. "All of you have chosen a great field of endeavor and your futures should be very bright."

Collins encouraged his audience to be passionate about their dreams, to explore and take risks, and to not be intimidated by people who tell them that something is impossible. Collins said, "Have fun doing the impossible!"

A prepared text of Dr. Collins' Commencement address is available on CEM's website at www.cem.com.

CEM Corporation, a private company based in Matthews, North Carolina, is the leading global company specializing in scientific solutions for critical laboratory applications. The Company has subsidiaries in the United Kingdom, Germany, Italy, France, and Japan, as well as a global network of distributors. CEM designs and manufactures systems for bioscience applications, life sciences, analytical laboratories and processing plants worldwide. The Company's products are used in many industries including pharmaceutical, biotech, chemical and food processing, as well as academic research.


'/>"/>
SOURCE CEM Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance
2. AEterna Zentaris Announces Appointment of Prof. Jurgen Engel, Ph.D. as New President and CEO
3. RainDance Technologies Appoints Olex Vice President, System Development
4. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
5. 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis
6. Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development
7. Bill Pollock, President and CEO of Pharmagistics Group, Named to PharmaVOICE List of 100 Most Inspiring and Influential Leaders in the Life Sciences
8. US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services
9. UltraShape Appoints Assaf Eyal as President & CEO
10. Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer
11. Anesiva Announces Appointment of William Houghton, M.D. as Senior Vice President and Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software ... State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , ... Tremblay, President and COO of STACS DNA. “In further expanding our capacity as a ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... Andrew D Zelenetz ... Published recently in Oncology ... touchONCOLOGY, Andrew D Zelenetz , discusses the ... is placing an increasing burden on healthcare systems ... With the patents on many biologics expiring, interest ...
(Date:6/23/2016)... CA (PRWEB) , ... June 23, 2016 , ... ... software, is exhibiting at the Pennsylvania Convention Center and will showcase its product’s ... conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials ...
Breaking Biology Technology:
(Date:6/15/2016)... , June 15, 2016 ... report titled "Gesture Recognition Market by Application Market - Global Industry ... - 2024". According to the report, the  global gesture ... in 2015 and is estimated to grow at ... billion by 2024.  Increasing application of ...
(Date:6/2/2016)... , June 2, 2016 The Department ... has awarded the 44 million US Dollar project, for the ... Vehicle Plates including Personalization, Enrolment, and IT Infrastructure , ... in the production and implementation of Identity Management Solutions. Numerous ... however Decatur was selected for the ...
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
Breaking Biology News(10 mins):